Published in J Biol Chem on July 30, 1999
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med (2006) 6.86
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A (2007) 3.85
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev (2003) 2.90
The genome of fowlpox virus. J Virol (2000) 2.30
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J Exp Med (2001) 2.07
Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol (2003) 2.07
Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol (2000) 1.86
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol (2011) 1.66
Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.65
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J Exp Med (2000) 1.52
A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J Exp Med (2001) 1.42
Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol (2001) 1.37
A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med (2000) 1.24
Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med (2003) 1.12
Molecular machinations: chemokine signals in host-pathogen interactions. Clin Microbiol Rev (2001) 1.07
Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J Virol (2008) 1.02
CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor. J Virol (2000) 1.00
KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res (2014) 0.99
Identification of human CCR8 as a CCL18 receptor. J Exp Med (2013) 0.98
The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. J Biol Chem (2009) 0.96
Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol (2010) 0.96
Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J Virol (2012) 0.93
Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells. J Virol (2004) 0.92
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation. J Virol (2003) 0.87
Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication. Recent Results Cancer Res (2014) 0.84
Cytokine homologs of human gammaherpesviruses. J Interferon Cytokine Res (2011) 0.83
Evolutionary aspects of oncogenic herpesviruses. Mol Pathol (2000) 0.79
The human cutaneous chemokine system. Front Immunol (2011) 0.79
The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor. Virol J (2008) 0.78
Human herpesvirus 8-encoded cytokines. Future Virol (2010) 0.77
Contribution of viral mimics of cellular genes to KSHV infection and disease. Viruses (2014) 0.76
Cultured Kaposi's sarcoma tumor cells exhibit a chemokine receptor repertoire that does not allow infection by HIV-1. BMC Dermatol (2001) 0.75
Chemokines encoded by herpesviruses. J Leukoc Biol (2017) 0.75
Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 23.81
Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A (1990) 13.34
Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J (1982) 8.16
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (1997) 6.70
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell (1993) 4.93
Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem (1991) 4.92
Neural and developmental actions of lithium: a unifying hypothesis. Cell (1989) 4.13
Chemokine receptors: gateways to inflammation and infection. Nat Med (1996) 3.56
RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med (1992) 3.25
Lymphotactin: a cytokine that represents a new class of chemokine. Science (1994) 2.74
Activation of dual T cell signaling pathways by the chemokine RANTES. Science (1995) 2.65
Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions (1989) 2.59
The mas oncogene encodes an angiotensin receptor. Nature (1988) 2.53
Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A (1999) 2.51
A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells. Biochem J (1988) 2.49
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24
The possible existence of multiple receptors for substance P. Naunyn Schmiedebergs Arch Pharmacol (1982) 2.18
Similar effects of substance P and related peptides on salivation and on phosphatidylinositol turnover in rat salivary glands. Mol Pharmacol (1980) 2.14
Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem (1993) 2.06
Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol (1994) 1.99
Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem (1993) 1.77
Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood (1994) 1.72
C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins. J Immunol (1994) 1.66
Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. Eur J Pharmacol (1983) 1.65
CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J Immunol (1998) 1.64
Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain. Nature (1988) 1.63
Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol (1995) 1.61
Receptor coupled events in bradykinin action: rapid production of inositol phosphates and regulation of cytosolic free Ca2+ in a neural cell line. EMBO J (1987) 1.59
myo-inositol pentakisphosphates. Structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate. Biochem J (1991) 1.57
Interleukin-16 or not? Nature (1996) 1.56
Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A (1999) 1.53
Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol (1998) 1.52
Molecular cloning and functional characterization of human lymphotactin. J Immunol (1995) 1.50
Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med (1994) 1.49
Peptide sequencing using the combination of edman degradation, carboxypeptidase digestion and fast atom bombardment mass spectrometry. Biochem Biophys Res Commun (1982) 1.48
Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. Br J Pharmacol (1992) 1.45
Thapsigargin, a new calcium-dependent epithelial anion secretagogue. Br J Pharmacol (1989) 1.41
Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol (2000) 1.38
Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochemistry (1995) 1.38
Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol (1995) 1.38
RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol (1992) 1.36
Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol (1995) 1.33
Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem (1995) 1.31
Biologic activities of the murine beta-chemokine TCA3. J Immunol (1994) 1.26
RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum Gene Ther (1996) 1.24
CD19 is functionally and physically associated with surface immunoglobulin. J Exp Med (1989) 1.24
Uncoupling of early signal transduction events from effector function in human peripheral blood neutrophils in response to recombinant macrophage inflammatory proteins-1 alpha and -1 beta. J Immunol (1993) 1.22
Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J Immunol (2000) 1.22
Purification and characterisation of a membrane-bound substance-P-degrading enzyme from human brain. Eur J Biochem (1981) 1.22
CC chemokines induce the generation of killer cells from CD56+ cells. Eur J Immunol (1996) 1.21
Calcium influx factor is synthesized by yeast and mammalian cells depleted of organellar calcium stores. Proc Natl Acad Sci U S A (1999) 1.17
RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J Exp Med (1996) 1.15
The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry (1993) 1.14
Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol (1993) 1.14
The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med (1987) 1.14
Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol (1995) 1.14
A vasopressin-like peptide in the mammalian sympathetic nervous system. Nature (1984) 1.13
Inositol trisphosphate and thapsigargin discriminate endoplasmic reticulum stores of calcium in rat brain. Biochem Biophys Res Commun (1990) 1.11
Phosphatidylinositol metabolism in cells transformed by polyomavirus middle T antigen. J Virol (1990) 1.10
Peptide receptors. Stepping up the pressure. Nature (1992) 1.09
Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J Exp Med (1992) 1.09
Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscler Thromb (1994) 1.08
Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate. Biochem Pharmacol (1995) 1.08
Evaluation of calcium influx factors from stimulated Jurkat T-lymphocytes by microinjection into Xenopus oocytes. J Biol Chem (1995) 1.08
Integrin receptors and RGD sequences in human keratinocyte migration: unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J Invest Dermatol (1992) 1.08
Chromatographic resolution of an intracellular calcium influx factor from thapsigargin-activated Jurkat cells. Evidence for multiple activities influencing calcium elevation in Xenopus oocytes. J Biol Chem (1995) 1.07
Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol (1996) 1.05
Thapsigargin, but not caffeine, blocks the ability of thyrotropin-releasing hormone to release Ca2+ from an intracellular store in GH4C1 pituitary cells. Biochem J (1990) 1.05
Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. 1989. Agents Actions (1994) 1.04
Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor alpha and interferon-gamma. Arthritis Rheum (1993) 1.04
Diverse molecular provocation of programmed cell death. Trends Biochem Sci (1996) 1.04
Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett (1998) 1.03
Characterization of metal ion-induced [3H]inositol hexakisphosphate binding to rat cerebellar membranes. J Biol Chem (1993) 1.02
Chemokine receptor CCR3 function is highly dependent on local pH and ionic strength. J Biol Chem (1997) 1.02
Primary sensory neurons migrate in response to the chemokine RANTES. J Neuroimmunol (1998) 1.01
Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol (1993) 1.00
Attenuation of agonist-induced desensitization of the rat substance P receptor by progressive truncation of the C-terminus. FEBS Lett (1994) 1.00
Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose. Clin Pharmacol Ther (2011) 0.99
Muscarinic cholinergic receptors in rat corpus striatum and regulation of guanosine cyclic 3',5'-monophosphate. Mol Pharmacol (1978) 0.99
IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1. J Leukoc Biol (1995) 0.99
Macrophage inflammatory protein-1beta induces migration and activation of human thymocytes. Blood (1998) 0.98
Pharmacological tools for perturbing intracellular calcium storage. Methods Cell Biol (1994) 0.98
Regulation of c-fos and c-jun protooncogene expression by the Ca(2+)-ATPase inhibitor thapsigargin. Proc Natl Acad Sci U S A (1991) 0.98
Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle. Mol Pharmacol (1988) 0.96
Sympathetic denervation impairs agonist-stimulated phosphatidylinositol metabolism in rat parotid glands. Biochem J (1983) 0.96
Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol (1995) 0.96
Functional substance P receptors on a rat pancreatic acinar cell line. J Neurosci (1985) 0.96
Protein kinase Cs. Coping with a growing family. Nature (1987) 0.95
Phosphatidic acid and lysophosphatidic acid stimulate receptor-regulated membrane currents in the Xenopus laevis oocyte. Arch Biochem Biophys (1992) 0.95
Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol (1999) 0.95
Synthesis and biological properties of enzyme-resistant analogues of substance P. Eur J Biochem (1981) 0.95
A monoclonal anti-idiotypic antibody to mu and delta opioid receptors. Brain Res Mol Brain Res (1991) 0.95
Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies. J Immunol (1982) 0.94
Molecular cloning and functional characterization of a novel member of the C-C chemokine family. J Immunol (1995) 0.93
Chemokines as mediators of allergic inflammation. Int Arch Allergy Immunol (1996) 0.93
IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D. J Immunol (1995) 0.93
The ras gene. Transformer and transducer. Nature (1987) 0.93
Development of macroglial cells in rat cerebellum. I. Use of antibodies to follow early in vivo development and migration of oligodendrocytes. J Neurocytol (1988) 0.92
Overexpression of RANTES using a recombinant adenovirus vector induces the tissue-directed recruitment of monocytes to the lung. J Immunol (1996) 0.92